Vance Terry 4
4 · ENANTA PHARMACEUTICALS INC · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Vance Terry
Director
Transactions
- Exercise/Conversion
Common Stock
2023-03-16$14.00/sh+5,800$81,200→ 21,095 total - Exercise/Conversion
Stock Option (right to buy)
2023-03-16−5,800→ 0 totalExercise: $14.00Exp: 2023-03-20→ Common Stock (5,800 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the option are fully vested and exercisable.